Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE

LATIn American sTUdy to Investigate the Clinical Performance of Sirolimus-eluting Stent With Abluminal-only bioDEgradable Polymeric Coating (Inspiron TM) in the Treatment of Native Coronary Artery Lesions.

Prospective, multicenter, single arm registry to monitor post-market clinical outcomes of patients treated with Inspiron Sirolimus-Eluting Stent with Biodegradable Polymer.

Prospective, multicenter, single arm registry to assess the safety and performance of Inspiron Sirolimus-Eluting Stent with Biodegradable Polymer for the treatment of "real world" patients.

Inclusion Criteria:

• All individuals aged over 18 years who signed the informed consent and had lesions in native coronary arteries treated only with Inspiron Sirolimus-Eluting stent.

Exclusion Criteria:

• Saphenous vein grafts or Mammary lesions;
• Individuals who have been treated within the last 6 months with another stent;
• Acute myocardial infarction with ST segment elevation;
• Chronic Total Occlusion